Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer - Related Studies

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

This study is ongoing, but not recruiting participants.

Study NCT00003583. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer-Related Problem/Condition
		Lung Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Small Cell
		Lung Neoplasms

3	More general conditions related to this trial
		Adenocarcinoma
		Carcinoma
		Carcinoma, Neuroendocrine
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		amifostine trihydrate
		cisplatin
		etoposide
		radiation therapy

5	Additional drug interventions recognized in this trial
		Amifostine

6	More general drug interventions related to this trial
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Radiation-Protective Agents

7	Sponsors listed in this trial
		University of Florida